Spotlight On: Actemra® (tocilizumab) / Tofidence™ (tocilizumab-bavi) / Tyenne® (tocilizumab-aazg) – June 2024

Tocilizumab Challenged Claim Types in IPRs: Claims are counted in each IPR, so claims from the same patent challenged in multiple IPRs are counted more than once. Within each IPR, claims are counted only once, whether they are challenged under § 102, § 103, or both….
By: Venable LLP
Previous Story

Goodwill Staffing Agency, GoodTemps, Confirms Recent Data Breach

Next Story

Litigation Minute: State Statutes and the Private Right of Action (Generative AI Series: Part Two of Three)